PMC:7556165 / 0-555 JSONTXT

{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T1","span":{"begin":78,"end":107},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"},{"id":"T2","span":{"begin":131,"end":134},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"},{"id":"T3","span":{"begin":202,"end":205},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A1","pred":"meddra_id","subj":"T1","obj":"http://purl.bioontology.org/ontology/MEDDRA/10050289"},{"id":"A2","pred":"meddra_id","subj":"T2","obj":"http://purl.bioontology.org/ontology/MEDDRA/10050289"},{"id":"A3","pred":"meddra_id","subj":"T3","obj":"http://purl.bioontology.org/ontology/MEDDRA/10050289"}],"text":"ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-transcriptional modulation by epigenetic mechanisms and microRNAs. Also, ACE2 expression is regulated post-translationally by glycosylation, phosphorylation, and shedding from the plasma membrane. ACE2 p"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T1","span":{"begin":78,"end":89},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_2719"}],"text":"ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-transcriptional modulation by epigenetic mechanisms and microRNAs. Also, ACE2 expression is regulated post-translationally by glycosylation, phosphorylation, and shedding from the plasma membrane. ACE2 p"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T1","span":{"begin":19,"end":29},"obj":"Species"},{"id":"T2","span":{"begin":19,"end":23},"obj":"Species"}],"attributes":[{"id":"A1","pred":"ncbi_taxonomy_id","subj":"T1","obj":"NCBItxid:2697049"},{"id":"A2","pred":"ncbi_taxonomy_id","subj":"T2","obj":"NCBItxid:694009"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-transcriptional modulation by epigenetic mechanisms and microRNAs. Also, ACE2 expression is regulated post-translationally by glycosylation, phosphorylation, and shedding from the plasma membrane. ACE2 p"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":30},"obj":"Sentence"},{"id":"T2","span":{"begin":31,"end":67},"obj":"Sentence"},{"id":"T3","span":{"begin":69,"end":77},"obj":"Sentence"},{"id":"T4","span":{"begin":78,"end":206},"obj":"Sentence"},{"id":"T5","span":{"begin":207,"end":295},"obj":"Sentence"},{"id":"T6","span":{"begin":296,"end":418},"obj":"Sentence"},{"id":"T7","span":{"begin":419,"end":548},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-transcriptional modulation by epigenetic mechanisms and microRNAs. Also, ACE2 expression is regulated post-translationally by glycosylation, phosphorylation, and shedding from the plasma membrane. ACE2 p"}

{"project":"LitCovid-sample-PD-UBERON","denotations":[{"id":"T1","span":{"begin":277,"end":281},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-transcriptional modulation by epigenetic mechanisms and microRNAs. Also, ACE2 expression is regulated post-translationally by glycosylation, phosphorylation, and shedding from the plasma membrane. ACE2 p"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"2","span":{"begin":0,"end":4},"obj":"Gene"},{"id":"3","span":{"begin":19,"end":29},"obj":"Species"},{"id":"46","span":{"begin":78,"end":109},"obj":"Gene"},{"id":"47","span":{"begin":111,"end":115},"obj":"Gene"},{"id":"48","span":{"begin":131,"end":134},"obj":"Gene"},{"id":"49","span":{"begin":202,"end":205},"obj":"Gene"},{"id":"50","span":{"begin":207,"end":211},"obj":"Gene"},{"id":"51","span":{"begin":296,"end":300},"obj":"Gene"},{"id":"52","span":{"begin":425,"end":429},"obj":"Gene"},{"id":"53","span":{"begin":549,"end":553},"obj":"Gene"},{"id":"67","span":{"begin":454,"end":458},"obj":"Gene"},{"id":"68","span":{"begin":347,"end":351},"obj":"Gene"},{"id":"70","span":{"begin":539,"end":547},"obj":"Gene"},{"id":"77","span":{"begin":277,"end":294},"obj":"Disease"}],"attributes":[{"id":"A52","pred":"pubann:denotes","subj":"52","obj":"Gene:59272"},{"id":"A50","pred":"pubann:denotes","subj":"50","obj":"Gene:59272"},{"id":"A53","pred":"pubann:denotes","subj":"53","obj":"Gene:59272"},{"id":"A67","pred":"pubann:denotes","subj":"67","obj":"Gene:159371"},{"id":"A77","pred":"pubann:denotes","subj":"77","obj":"MESH:D011014"},{"id":"A3","pred":"pubann:denotes","subj":"3","obj":"Tax:2697049"},{"id":"A51","pred":"pubann:denotes","subj":"51","obj":"Gene:59272"},{"id":"A70","pred":"pubann:denotes","subj":"70","obj":"Gene:43740571"},{"id":"A46","pred":"pubann:denotes","subj":"46","obj":"Gene:59272"},{"id":"A47","pred":"pubann:denotes","subj":"47","obj":"Gene:59272"},{"id":"A2","pred":"pubann:denotes","subj":"2","obj":"Gene:59272"},{"id":"A49","pred":"pubann:denotes","subj":"49","obj":"Gene:1636"},{"id":"A68","pred":"pubann:denotes","subj":"68","obj":"Gene:159371"},{"id":"A48","pred":"pubann:denotes","subj":"48","obj":"Gene:1636"}],"text":"ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-transcriptional modulation by epigenetic mechanisms and microRNAs. Also, ACE2 expression is regulated post-translationally by glycosylation, phosphorylation, and shedding from the plasma membrane. ACE2 p"}

{"project":"LitCovid-sample-UniProt","denotations":[{"id":"T1","span":{"begin":0,"end":4},"obj":"Protein"},{"id":"T2","span":{"begin":78,"end":109},"obj":"Protein"},{"id":"T17","span":{"begin":111,"end":115},"obj":"Protein"},{"id":"T18","span":{"begin":131,"end":134},"obj":"Protein"},{"id":"T43","span":{"begin":202,"end":205},"obj":"Protein"},{"id":"T68","span":{"begin":207,"end":211},"obj":"Protein"},{"id":"T69","span":{"begin":296,"end":300},"obj":"Protein"},{"id":"T70","span":{"begin":425,"end":429},"obj":"Protein"},{"id":"T71","span":{"begin":549,"end":553},"obj":"Protein"}],"attributes":[{"id":"A1","pred":"uniprot_id","subj":"T1","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"},{"id":"A2","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"},{"id":"A3","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q9NRA7"},{"id":"A4","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q9BYF1"},{"id":"A5","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q99N71"},{"id":"A6","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q99N70"},{"id":"A7","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q8R0I0"},{"id":"A8","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q86WT0"},{"id":"A9","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q6UWP0"},{"id":"A10","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q5RFN1"},{"id":"A11","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q5EGZ1"},{"id":"A12","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q58DD0"},{"id":"A13","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q56NL1"},{"id":"A14","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q56H28"},{"id":"A15","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/Q2PGE2"},{"id":"A16","pred":"uniprot_id","subj":"T2","obj":"https://www.uniprot.org/uniprot/C7ECU1"},{"id":"A17","pred":"uniprot_id","subj":"T17","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"},{"id":"A18","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q9GLN7"},{"id":"A19","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q9GLN6"},{"id":"A20","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q9EQM9"},{"id":"A21","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q8CFN1"},{"id":"A22","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q7TMC6"},{"id":"A23","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q7M4L4"},{"id":"A24","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q6GTS2"},{"id":"A25","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q59GY8"},{"id":"A26","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q53YX9"},{"id":"A27","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q50JE5"},{"id":"A28","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q10751"},{"id":"A29","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q0GA41"},{"id":"A30","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/P47820"},{"id":"A31","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/P22968"},{"id":"A32","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/P22967"},{"id":"A33","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/P22966"},{"id":"A34","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/P12822"},{"id":"A35","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/P12821"},{"id":"A36","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/P12820"},{"id":"A37","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/P09470"},{"id":"A38","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/O02852"},{"id":"A39","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/E7EU16"},{"id":"A40","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/B4DXI3"},{"id":"A41","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/B0LPF0"},{"id":"A42","pred":"uniprot_id","subj":"T18","obj":"https://www.uniprot.org/uniprot/Q9VJV3"},{"id":"A43","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q9GLN7"},{"id":"A44","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q9GLN6"},{"id":"A45","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q9EQM9"},{"id":"A46","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q8CFN1"},{"id":"A47","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q7TMC6"},{"id":"A48","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q7M4L4"},{"id":"A49","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q6GTS2"},{"id":"A50","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q59GY8"},{"id":"A51","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q53YX9"},{"id":"A52","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q50JE5"},{"id":"A53","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q10751"},{"id":"A54","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q0GA41"},{"id":"A55","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/P47820"},{"id":"A56","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/P22968"},{"id":"A57","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/P22967"},{"id":"A58","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/P22966"},{"id":"A59","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/P12822"},{"id":"A60","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/P12821"},{"id":"A61","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/P12820"},{"id":"A62","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/P09470"},{"id":"A63","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/O02852"},{"id":"A64","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/E7EU16"},{"id":"A65","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/B4DXI3"},{"id":"A66","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/B0LPF0"},{"id":"A67","pred":"uniprot_id","subj":"T43","obj":"https://www.uniprot.org/uniprot/Q9VJV3"},{"id":"A68","pred":"uniprot_id","subj":"T68","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"},{"id":"A69","pred":"uniprot_id","subj":"T69","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"},{"id":"A70","pred":"uniprot_id","subj":"T70","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"},{"id":"A71","pred":"uniprot_id","subj":"T71","obj":"https://www.uniprot.org/uniprot/Q9UFZ6"}],"text":"ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-transcriptional modulation by epigenetic mechanisms and microRNAs. Also, ACE2 expression is regulated post-translationally by glycosylation, phosphorylation, and shedding from the plasma membrane. ACE2 p"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T1","span":{"begin":277,"end":281},"obj":"Body_part"},{"id":"T2","span":{"begin":532,"end":547},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma63841"}],"text":"ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-transcriptional modulation by epigenetic mechanisms and microRNAs. Also, ACE2 expression is regulated post-translationally by glycosylation, phosphorylation, and shedding from the plasma membrane. ACE2 p"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T1","span":{"begin":19,"end":29},"obj":"Disease"},{"id":"T2","span":{"begin":19,"end":23},"obj":"Disease"},{"id":"T3","span":{"begin":282,"end":294},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"}],"text":"ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-transcriptional modulation by epigenetic mechanisms and microRNAs. Also, ACE2 expression is regulated post-translationally by glycosylation, phosphorylation, and shedding from the plasma membrane. ACE2 p"}

{"project":"LitCovid-sample-PD-MAT","denotations":[{"id":"T1","span":{"begin":277,"end":281},"obj":"http://purl.obolibrary.org/obo/MAT_0000135"}],"text":"ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-transcriptional modulation by epigenetic mechanisms and microRNAs. Also, ACE2 expression is regulated post-translationally by glycosylation, phosphorylation, and shedding from the plasma membrane. ACE2 p"}

{"project":"LitCovid-sample-PD-GO-BP-0","denotations":[{"id":"T1","span":{"begin":282,"end":294},"obj":"http://purl.obolibrary.org/obo/GO_0006954"},{"id":"T2","span":{"begin":327,"end":342},"obj":"http://purl.obolibrary.org/obo/GO_0006351"},{"id":"T3","span":{"begin":352,"end":367},"obj":"http://purl.obolibrary.org/obo/GO_0006351"},{"id":"T4","span":{"begin":459,"end":474},"obj":"http://purl.obolibrary.org/obo/GO_0006412"},{"id":"T5","span":{"begin":478,"end":491},"obj":"http://purl.obolibrary.org/obo/GO_0070085"},{"id":"T6","span":{"begin":493,"end":508},"obj":"http://purl.obolibrary.org/obo/GO_0016310"}],"text":"ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-transcriptional modulation by epigenetic mechanisms and microRNAs. Also, ACE2 expression is regulated post-translationally by glycosylation, phosphorylation, and shedding from the plasma membrane. ACE2 p"}

{"project":"LitCovid-sample-GO-BP","denotations":[{"id":"T1","span":{"begin":282,"end":294},"obj":"http://purl.obolibrary.org/obo/GO_0006954"},{"id":"T2","span":{"begin":327,"end":342},"obj":"http://purl.obolibrary.org/obo/GO_0006351"},{"id":"T3","span":{"begin":352,"end":367},"obj":"http://purl.obolibrary.org/obo/GO_0006351"},{"id":"T4","span":{"begin":459,"end":474},"obj":"http://purl.obolibrary.org/obo/GO_0006412"},{"id":"T5","span":{"begin":478,"end":491},"obj":"http://purl.obolibrary.org/obo/GO_0070085"},{"id":"T6","span":{"begin":493,"end":508},"obj":"http://purl.obolibrary.org/obo/GO_0016310"}],"text":"ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-transcriptional modulation by epigenetic mechanisms and microRNAs. Also, ACE2 expression is regulated post-translationally by glycosylation, phosphorylation, and shedding from the plasma membrane. ACE2 p"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2","span":{"begin":0,"end":4},"obj":"Gene"},{"id":"3","span":{"begin":19,"end":29},"obj":"Species"},{"id":"46","span":{"begin":78,"end":109},"obj":"Gene"},{"id":"47","span":{"begin":111,"end":115},"obj":"Gene"},{"id":"48","span":{"begin":131,"end":134},"obj":"Gene"},{"id":"49","span":{"begin":202,"end":205},"obj":"Gene"},{"id":"50","span":{"begin":207,"end":211},"obj":"Gene"},{"id":"51","span":{"begin":296,"end":300},"obj":"Gene"},{"id":"52","span":{"begin":425,"end":429},"obj":"Gene"},{"id":"53","span":{"begin":549,"end":553},"obj":"Gene"},{"id":"67","span":{"begin":454,"end":458},"obj":"Gene"},{"id":"68","span":{"begin":347,"end":351},"obj":"Gene"},{"id":"70","span":{"begin":539,"end":547},"obj":"Gene"},{"id":"77","span":{"begin":277,"end":294},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"tao:has_database_id","subj":"2","obj":"Gene:59272"},{"id":"A3","pred":"tao:has_database_id","subj":"3","obj":"Tax:2697049"},{"id":"A46","pred":"tao:has_database_id","subj":"46","obj":"Gene:59272"},{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"Gene:59272"},{"id":"A48","pred":"tao:has_database_id","subj":"48","obj":"Gene:1636"},{"id":"A49","pred":"tao:has_database_id","subj":"49","obj":"Gene:1636"},{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"Gene:59272"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"Gene:59272"},{"id":"A52","pred":"tao:has_database_id","subj":"52","obj":"Gene:59272"},{"id":"A53","pred":"tao:has_database_id","subj":"53","obj":"Gene:59272"},{"id":"A67","pred":"tao:has_database_id","subj":"67","obj":"Gene:159371"},{"id":"A68","pred":"tao:has_database_id","subj":"68","obj":"Gene:159371"},{"id":"A70","pred":"tao:has_database_id","subj":"70","obj":"Gene:43740571"},{"id":"A77","pred":"tao:has_database_id","subj":"77","obj":"MESH:D011014"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-transcriptional modulation by epigenetic mechanisms and microRNAs. Also, ACE2 expression is regulated post-translationally by glycosylation, phosphorylation, and shedding from the plasma membrane. ACE2 p"}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":30},"obj":"Sentence"},{"id":"T2","span":{"begin":31,"end":67},"obj":"Sentence"},{"id":"T3","span":{"begin":69,"end":77},"obj":"Sentence"},{"id":"T4","span":{"begin":78,"end":206},"obj":"Sentence"},{"id":"T5","span":{"begin":207,"end":295},"obj":"Sentence"},{"id":"T6","span":{"begin":296,"end":418},"obj":"Sentence"},{"id":"T7","span":{"begin":419,"end":548},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives\n\nAbstract\nAngiotensin-converting enzyme 2 (ACE2) is related to ACE but turned out to counteract several pathophysiological actions of ACE. ACE2 exerts antihypertensive and cardioprotective effects and reduces lung inflammation. ACE2 is subjected to extensive transcriptional and post-transcriptional modulation by epigenetic mechanisms and microRNAs. Also, ACE2 expression is regulated post-translationally by glycosylation, phosphorylation, and shedding from the plasma membrane. ACE2 p"}